CHU Reims

Reims 51092

2 studies enrolling now · 4 studies all time

What they study most

Advanced Cholangiocarcinoma, ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma, FGFR2 Gene Rearrangements, Open Midline Laparotomy, Unresectable Hepatocellular Carcinoma

Studies at this site

• Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence — Recruiting now
• Prophylactic Reinforcement of Ventral Abdominal Incisions Trial — Recruiting now
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer — Completed